Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q/A, Date: 2015-12-28, XBRL Interactive Financials
Original SEC Filing: Click here
Webplus: CPHI/20151228/10-Q.A/1/000.htm SEC Original: cphi10qa093015.htm
o Large accelerated filer
Webplus: CPHI/20151228/10-Q.A/2_EX-31.1/000.htm SEC Original: cphi10qaex311093015.htm
CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
Webplus: CPHI/20151228/10-Q.A/3_EX-31.2/000.htm SEC Original: cphi10qaex312093015.htm
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,
Webplus: CPHI/20151228/10-Q.A/4_EX-32.1/000.htm SEC Original: cphi10qaex321093015.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321093015.htm
Company Information:
Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q/A, Date: 2015-12-28, XBRL Interactive FinancialsCIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD
HAINAN PROVINCE 570216
-
- Forum
- Topics
- Last Post
Leave A Comment
You must be logged in to post a comment.